生物学方法在艾滋病抗病毒治疗服药依从性评估中的应用
摘要
高效抗逆转录病毒疗法（ highly active antiretroviral thera-py， HAART）由多种抗病毒药物共同组成，目前国内治疗HIV-1感染者的标准治疗方案为2种核苷类逆转录酶抑制剂（ nucleoside reverse transcriptase inhibitors， NRTIs）配合1种非核苷类逆转录酶抑制剂（ non-nucleoside reverse transcriptase inhibitors， NNRTIs）或蛋白酶类抑制剂（ protease inhibitors， PIs）［1］。高效抗逆转录病毒疗法降低了HIV-1感染者的发病率和死亡率［2-3］。
出处
《中华微生物学和免疫学杂志》
CAS
CSCD
北大核心
2015年第4期310-313,共4页
Chinese Journal of Microbiology and Immunology
参考文献28
-
1张福杰.国家免费艾滋病抗病毒治疗手册[M].3版.北京:人民卫生出版社,2012.
-
2Hirschel B, Francioli P. Progress and problems in the fight against AIDS[J]. N Engl J Med, 1998, 338(13) : 906-908.
-
3Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human im- munodeficiency virus infection and CD4 cell counts of 200 per cu- bic millimeter or less. AIDS Clinical Trials Group 320 Study Team [J]]. N Engl J Med, 1997, 337(11) : 725-733.
-
4Bernard L, Peytavin G, Vuagnat A, et at. Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy [J]. Lancet, 1998, 352(9142):1757-1758.
-
5Segeral O, Madec , Ban B, et al. Simplified assessment of an- tiretroviral adherence and prediction of virological efficacy in HIV- infected patients in Cambodia[ J]. AIDS Res Treat, 2010, 2010: 142076.
-
6Gandhi M, Ameli N, Bacchetti P, et al. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral thera- py[J]. Clin Infect Dis, 2011, 52(10) : 1267-1275.
-
7Gandhi M, Greenblatt RM. Hair it is: the long and short of moni- toring antiretroviral treatment [ J]. Ann Intern Med, 2002, 137 ( 8 ) : 696-697.
-
8Palella FJ Jr, De|aney KM, Moorman AC, et al. Declining mor- bidity and mortality among patients with advanced human immuno- deficiency virus infection. HIV Outpatient Study Investigators[ J]. N Engl J Med, 1998, 338(13) : 853-860.
-
9Minzi O, Mugoyela V, Gustafsson L. Correlation between lamivu- dine plasma concentrations and patient self-reported adherence to antiretrovital treatment in experienced HIV patients [ J ]. Ther Clin Risk Manag, 2011,7: 441-446.
-
10Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral thera- py adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring[J]. Clin Infect Dis, 2001, 33(8) : 1417-1423.
-
1李会强,常艳敏,李乃昶,杨湘龙,姚智.急性胰腺炎患者IL-6、TNFα水平测定及临床意义[J].天津医科大学学报,2000,6(2):151-152. 被引量：1
-
2边素艳,盖鲁粤,郭子宽.骨髓间充质干细胞移植治疗缺血性心脏病的机制[J].组织工程与重建外科杂志,2007,3(6):350-352. 被引量：5
-
3杨建林,樊晓晖.流感病毒引起细胞凋亡因素的研究进展[J].中国热带医学,2006,6(9):1676-1678. 被引量：2
-
4沈成利,吴昊.抗HIV治疗的副作用(一)——核苷类及非核苷类逆转录酶抑制剂[J].中国艾滋病性病,2005,11(3):228-229. 被引量：10
-
5董吉祥,陆安山,刘志达,韩惠琴,谢炜,沈华英,张学光.雷公藤多甙对狼疮性肾炎患者外周血IL-6、sIL-2R的影响研究[J].中国免疫学杂志,1999,15(5):238-238. 被引量：7
-
6侯莉,严丽荣,金星进,王建娟.糖尿病患者血清基质金属蛋白酶9和血小板活化因子水平变化及意义[J].山东医药,2010,50(17):5-7. 被引量：1
-
7张梓楠,冯莹,曹惠芳,张萍,徐晶,李维浩,何荷.谷胱甘肽过氧化物酶与脂质过氧化物在哮喘发病前后变化及意义[J].西部医学,2015,27(1):78-79. 被引量：4
-
8尉太疑,刘玉华,卫彬.^(131)I治疗重度甲状腺肿大并发甲状腺功能亢进症26例分析[J].实用医技杂志,2010,17(3):259-260. 被引量：1
-
9肖雅云.矽肺发病机理与国内治疗研究现况[J].劳动医学,1998,15(4):223-224. 被引量：2
-
10孙宏清.Effects of different anti-HIV therapies on progression of hepatitis C in HCV /HIV-coinfected patients[J].China Medical Abstracts(Internal Medicine),2014,31(1):42-43.
